
Segundo premio de la tarde, esta vez a la #Innovación a @EdwardsEurope , empresa líder a nivel mundial en innovación cardiaca estructural. #innovacion #edwardslifesciences #PremiosEconomia3 #Valencia #grupoemotiva

Follow us to engage with our societal mission #UnifyingGenerations, fight #CardiovascularDisease, or for #MedTech & corp. updates from @EdwardsLifesci in Europe

Segundo premio de la tarde, esta vez a la #Innovación a @EdwardsEurope , empresa líder a nivel mundial en innovación cardiaca estructural. #innovacion #edwardslifesciences #PremiosEconomia3 #Valencia #grupoemotiva

➡ The effects of ageism in healthcare impact everyone: individuals, families and societies, by failing to recognise the potential of older generations to contribute to society. The "𝗖𝗼𝗻𝗳𝗿𝗼𝗻𝘁𝗶𝗻𝗴 𝗔𝗴𝗲𝗶𝘀𝗺 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲" report, produced by Gupta Strategists and supported by Edwards Lifesciences, explores age discrimination across the Dutch healthcare system 🇳🇱 and advocates for age-neutral policies, better education for healthcare providers, and inclusive research to ensure older adults receive the care they deserve. Find out more: gupta-strategists.nl/en/rese… #AgeDiscrimination #HealthcareForAll #HealthcareInnovation #HealthcareEquity #AgeismAwareness

🏥🇳🇱 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 𝘁𝗵𝗮𝘁 𝗲𝘃𝗲𝗿𝘆 𝘆𝗲𝗮𝗿, 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝟰𝟱𝟬,𝟬𝟬𝟬 𝗮𝗻𝗱 𝟲𝟱𝟬,𝟬𝟬𝟬 𝗼𝗹𝗱𝗲𝗿 𝗮𝗱𝘂𝗹𝘁𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗡𝗲𝘁𝗵𝗲𝗿𝗹𝗮𝗻𝗱𝘀 𝗳𝗮𝗰𝗲 𝗺𝗶𝘀𝘀𝗲𝗱 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗲𝘀, 𝗱𝗲𝗹𝗮𝘆𝗲𝗱 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀, 𝗮𝗻𝗱 𝗿𝗲𝗱𝘂𝗰𝗲𝗱 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝘃𝗲 𝗰𝗮𝗿𝗲 due to ageism. It’s time to address the gap. Find out more here in the latest Gupta Strategists report: gupta-strategists.nl/en/rese… #AgeDiscrimination #HealthcareForAll #HealthcareInnovation #HealthcareEquity #AgeismAwareness

🫀🇪🇺 This week, 𝘁𝗵𝗲 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗨𝗻𝗶𝗼𝗻 𝗺𝗮𝗱𝗲 𝗵𝘂𝗴𝗲 𝘀𝘁𝗲𝗽𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗯𝗲𝗻𝗲𝗳𝗶𝘁 𝗼𝗳 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘀𝘂𝗳𝗳𝗲𝗿𝗶𝗻𝗴 𝗳𝗿𝗼𝗺 𝗖𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗗𝗶𝘀𝗲𝗮𝘀𝗲! European Countries adopted Council Conclusions on Cardiovascular Health, which marks a historic milestone for cardiovascular patients all over Europe! This sets the stage for the first-ever EU Cardiovascular Health Plan to tackle EU’s biggest killer. “By prioritizing cardiovascular health, the European Union is taking a transformative step that will impact millions of lives for the years to come. As pioneers in structural heart disease innovation, we will continue to push boundaries, collaborating with stakeholders to transform care and improve outcomes for patients. We welcome the European union's strong commitment to heart health paving the way for a healthier future”- Annette Brüls, Edwards Lifesciences’ Corporate Vice President EMEA, Canada, and Latin America. The future plan promises to improve prevention, early detection, and equitable access to innovative treatment. Read more on: consilium.europa.eu/en/press… #CVHealth #CVHealthPlan #CVD #Cardiovascular

Let’s talk about age discrimination and the 𝘂𝗻𝗱𝗲𝗿𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 & 𝘂𝗻𝗱𝗲𝗿𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗶𝗻 𝗼𝗹𝗱𝗲𝗿 𝗮𝗱𝘂𝗹𝘁𝘀. The "𝗖𝗼𝗻𝗳𝗿𝗼𝗻𝘁𝗶𝗻𝗴 𝗔𝗴𝗲𝗶𝘀𝗺 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲" report, produced by Gupta Strategists and supported by Edwards Lifesciences, explores age discrimination across the Dutch healthcare system 🇳🇱 . For actionable solutions to drive equitable care, click here to learn more: gupta-strategists.nl/en/rese… #AgeDiscrimination #HealthcareForAll #HealthcareInnovation #HealthcareEquity #AgeismAwareness

The #CouncilConclusions being approved is not the only announcement of today! Commissioner for Health Mr Olivér Várhelyi states that the European Commission "will develop a new European Cardiovascular Health Plan", as it aims to "put front and centre cardiovascular health" in the new mandate, an ambition EACH Partners have been calling for! This is great news for the cardiovascular community across Europe! lnkd.in/eUHNfNwp #EUCVHPlan #CVHealthForAll
Approved 💚 ! Council Conclusions on the Improvement of Cardiovascular Health in the EU: lnkd.in/ew79yBnP Read the Press Release from EACH here: lnkd.in/eQQYFUZA

Big thank you to everyone involved for their research and contributions at #ISPOREurope 2024, making innovation possible and improving patient care.

Global Assessment of Pre-Market Approval Pathways for Medical Devices: Highlighting the Need for Harmonization 🧬 This study from SDA Bocconi, presented by Francesco Malandrini calls for more consistent regulations for approving medical devices to make it easier to bring new treatments to market. 🔗ispor.org/conferences-educat…

Hospitalized Mitral Regurgitation Patients in Italy 🇮🇹 Presented by Paolo Sciattella from Faculty of Economics, University of Rome “Tor Vergata”. This analysis identifies the number of hospitalised patients with a Degenerative Mitral Regurgitation or Functional Mitral Regurgitation diagnosis in Italy, reporting the adoption of repairing procedures in the country and the resort to reintervention. 🔗ispor.org/conferences-educat… #FMR #DMR

TAVI vs Surgery in Symptomatic Severe Aortic Stenosis Patients at Low Surgical Mortality Risk in Belgium 🇧🇪 An updated cost-utility analysis using 5-year data from the PARTNER 3 trial confirms previously published results showing that TAVI is a dominant alternative to Surgery in low-risk patients with symptomatic severe aortic stenosis in Belgium. 🔗ispor.org/heor-resources/pre…

Economic Evaluation of TAVI Relative to Other Interventions 🏥 This targeted literature review compares and benchmarks the cost-effectiveness of #TAVI relative to treatments for other cardiovascular diseases and oncology. 🔗 ispor.org/heor-resources/pre…

Cost-Effectiveness of TAVI in Low Surgical Risk Symptomatic Severe Aortic Stenosis Patients in Brazil 🇧🇷 This research compares the cost-effectiveness of #TAVI vs traditional surgery in low surgical risk severe aortic stenosis patients in Brazil, showing TAVI can be a cost-effective option. 🔗ispor.org/heor-resources/pre…

The Burden of Severe Symptomatic Aortic Stenosis in Spain 🇪🇸 This study looks at the growing number of severe aortic stenosis cases in Spain and how capacity enhancing innovations like #TAVI can help the healthcare systems manage the demand for care. 🔗ispor.org/heor-resources/pre…

Inequalities in Accessing Aortic Valve Replacement in England 🏴 This study discusses the #disparities in access to heart valve replacement in England, highlighting that women and people from deprived areas are less likely to receive treatment. 🔗ispor.org/heor-resources/pre…

A Look back at our participation at this year's #ISPOREurope held in Barcelona. ISPOR is a leading global conference where experts discuss and share the latest Health economics and outcomes research (#HEOR) . Our team, together with academic partners, presented several impactful research posters. These posters highlighted the latest evidence and findings in Structural Heart Disease and medical devices, driven by our commitment and involvement to improving patient care and healthcare efficiency. 🧵An overview of the different posters presented.

In celebration of #WorldScienceDay, this year’s theme, #GlobalScience for #GlobalWellbeing, highlights the role of science in global health. Join @HEUEFS in advancing medical science. Engage with our survey to shape the future of #MedTech in Europe. 🔗bit.ly/HEU-EFS_Survey